How I Treat AML: When Patients Ask If AML Can Be Inherited, What Do I Tell Them?
Lucy Godley, MD, PhD, The University of Chicago
Saturday, September 9, 2017 11:55 a.m.
Fairmont Chicago, Millennium Park, Chicago, IL
The importance of germline susceptibility to hematopoietic malignancies is increasingly recognized, and patient diagnosis requires a high index of suspicion, familiarity with the known inherited syndromes, and knowledge of clinical testing options. This session will cover common scenarios in which germline syndromes should be considered and practical aspects of arranging testing. Dr. Godley will outline the major recognized syndromes and how they present clinically.
About the Speaker
Lucy Godley, MD, PhD, is a Professor of Medicine and Human Genetics at The University of Chicago. She is a physician-scientist with expertise in the genetic predisposition to hematopoietic malignancies. Through her work with families with multiple cases of hematologic malignancies, Dr. Godley has raised awareness of the role of inherited susceptibility mutations in driving hematopoietic malignancies, contributed to the identification of novel syndromes, and outlined parameters for clinical testing and surveillance guidelines for at-risk individuals.
back to top